NASDAQ:BSPM

Biostar Pharmaceuticals Stock Insider Trading

etoro logo Buy BSPM
*Your capital is at risk
$0.0001
+0 (+0%)
At Close: Jul 31, 2026

Biostar Pharmaceuticals Stock Insider Power

Based on the 48 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 1.05B and sold 0 BSPM shares in the last 48 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 48 transactions)
0
Buy 1.05B shares
Sell 0 shares
100% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jun 02, 2011
Buy
Common Stock
P-Purchase
Wang Ronghua
Chairman, CEO
CEO / President 12 200
Value: $15.7K
Jun 01, 2011
Buy
Common Stock
P-Purchase
Wang Ronghua
Chairman, CEO
CEO / President 1 700
Value: $2K
Jun 01, 2011
Buy
Common Stock
P-Purchase
Wang Ronghua
Chairman, CEO
CEO / President 1 300
Value: $2K
Jun 01, 2011
Buy
Common Stock
P-Purchase
Wang Ronghua
Chairman, CEO
CEO / President 200
Value: $274
Jun 01, 2011
Buy
Common Stock
P-Purchase
Wang Ronghua
Chairman, CEO
CEO / President 100
Value: $138
Jun 01, 2011
Buy
Common Stock
P-Purchase
Wang Ronghua
Chairman, CEO
CEO / President 1 700
Value: $2K
Jun 01, 2011
Buy
Common Stock
P-Purchase
Wang Ronghua
Chairman, CEO
CEO / President 2 500
Value: $3K
Jun 01, 2011
Buy
Common Stock
P-Purchase
Wang Ronghua
Chairman, CEO
CEO / President 1
Value: $1
Jun 01, 2011
Buy
Common Stock
P-Purchase
Wang Ronghua
Chairman, CEO
CEO / President 1 811
Value: $2K
Jun 01, 2011
Buy
Common Stock
P-Purchase
Wang Ronghua
Chairman, CEO
CEO / President 100
Value: $138
Jun 01, 2011
Buy
Common Stock
P-Purchase
Wang Ronghua
Chairman, CEO
CEO / President 200
Value: $274
Jun 01, 2011
Buy
Common Stock
P-Purchase
Wang Ronghua
Chairman, CEO
CEO / President 1 300
Value: $2K
Jun 01, 2011
Buy
Common Stock
P-Purchase
Wang Ronghua
Chairman, CEO
CEO / President 1 700
Value: $2K
Jun 01, 2011
Buy
Common Stock
P-Purchase
Wang Ronghua
Chairman, CEO
CEO / President 1 700
Value: $2K
Jun 01, 2011
Buy
Common Stock
P-Purchase
Wang Ronghua
Chairman, CEO
CEO / President 2 500
Value: $3K
Jun 01, 2011
Buy
Common Stock
P-Purchase
Wang Ronghua
Chairman, CEO
CEO / President 1 811
Value: $2K
Jun 01, 2011
Buy
Common Stock
P-Purchase
Wang Ronghua
Chairman, CEO
CEO / President 1
Value: $1
May 19, 2011
Buy
Common Stock
P-Purchase
Pan Zibing
Chief Financial Officer
C-Suite Officer 30 000
Value: $42.3K
May 19, 2011
Buy
Common Stock
P-Purchase
Pan Zibing
Chief Financial Officer
C-Suite Officer 30 000
Value: $42.3K
Oct 22, 2009
Buy
Options to purchase Common Stock
Wang Ronghua
Chairman, CEO
CEO / President 200 000
Value: $520.0K
Oct 22, 2009
Buy
Options to purchase Common Stock
Wang Ronghua
Chairman, CEO
CEO / President 200 000
Value: $520.0K
Nov 01, 2007
Buy
Common Stock
Wang Ronghua
Chairman, CEO
CEO / President 0
Value: $0
Nov 01, 2007
Buy
Common Stock
Wang Ronghua
Chairman, CEO
CEO / President 0
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT BIOSTAR PHARMACEUTICALS INC
Biostar Pharmaceuticals
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides 12 other OTC products and 17 prescription-based pharmaceuticals. The company's OTC products also comprise Ganwang compound p...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE